Resources

Errors are likely to result when diagnosing type 1 or 2 diabetes based on a measurement of basal fasting C-peptide (CP), and 6-minute post-glucagon-stimulated C-peptide (CPS).

Diabetes may become more common with age because of a decline in the function of mitochondria, the powerhouses of the body’s cells.

Aggressive blood pressure control may be the most important factor in preventing adverse outcomes in patients with type 2 diabetes.

Quality of care, not availability of care, appears to be the key to preventing hospitalization among patients with diabetes, Dr. James Bailey said at the southern regional meeting of the American Federation for Medical Research.

Enalapril treatment resulted in an absolute risk reduction of 22.4 percentage points for the development of clinical albuminuria over five years.

Increases in blood pressure in young adulthood precede the development of type 2 diabetes in middle age.

Could this be in store for the U.S. and other countries?

After 16 weeks of treatment, mean reductions of HbA1c were -1.6% for the repaglinide group and -1.0% for the nateglinide group.

Rofecoxib significantly increased systolic blood pressure, while celecoxib (Celebrex) and naproxen did not.

ACE-inhibitors or calcium antagonists may be better choices.